The core activity of Rivopharm is the development, manufacture and marketing of pharmaceutical products, including generic and branded medicines, dietary supplements and other health products. The company also provides services such as product formulation, packaging and regulatory affairs, and operates in more than 60 countries worldwide.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Prescription generic medicines in oral dosage forms for chronic and acute treatments; tablets, capsules, blister and bottle packaging, across many therapeutic areas.
Over-the-counter (OTC) medicines
OTC medicines in oral dosage forms, in particular tablets and capsules, offered with blister and bottle packaging for various everyday needs.
Dietary supplements
Dietary supplements in different oral forms, with capsules, tablets, vials and drops; range including products for skin, heart, sleep, eyes and joints.
Pharmaceutical manufacturing and packaging
Manufacture of oral solid dosage forms, packaging of tablets and capsules, blister and bottle filling, with facilities inspected and approved by Swiss authorities and the FDA.
Analytical development and validation
Analytical development and validation for pharmaceutical products, supporting the development and industrialisation of formulations.
Pharmaceutical formulation development
Pharmaceutical formulation development, including modified-release dosage forms, with in-house services and co-development projects.
Scale-up and process development
Scale-up, process development and validation for pharmaceutical production, from development transfer to manufacturing.
QC analysis and release
Quality control analyses and product release, integrated into the pharmaceutical manufacturing and validation workflow.
Contract pharmaceutical packaging
Packaging of pharmaceutical oral dosage forms in blisters and/or bottles for clients’ formulations, with flexibility on dosing technologies.
Regulatory affairs and registration
Regulatory support, national submission or DCP procedure, coordinating approval and product registration to reduce time to market.
Direct commercialisation in selected markets
Direct commercialisation of the products in selected countries, in addition to sales via partners and customers.
Comparisons
Rivopharm SA in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Rivopharm SA by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Rivopharm SA has claimed this profile, we'll publish editorial articles and case studies here together.